CAS: 19449-26-4; N,N-Dimethyl-1,3-Dioxolan-2-Amine

相似化合物

5754-35-8 1190197-97-7 87227-41-6

上下游产品

CAS号107-21-1 乙二醇 | CAS号1188-33-6 N,N-二甲基甲酰胺二乙基缩醛 | CAS号3646-10-4 1,4,6,9-tetraox... | CAS号4637-24-5 N,N-二甲基甲酰胺二甲基缩醛 | CAS号1073-75-2 2-(1,3,2-dioxap... | CAS号4746-97-8 1,4-环己二酮单乙二醇缩酮 | CAS号183-97-1 1,4-环己二酮双(乙烯乙缩醛) | CAS号20485-86-3 2-chloroethyl N... | CAS号107-21-1 乙二醇 | CAS号68-12-2 N,N-二甲基甲酰胺 | CAS号96-49-1 碳酸乙烯酯 | CAS号140-08-9 亚磷酸三(2-氯乙基)酯 | CAS号687-48-9 二甲基氨基甲酸乙酯

📜乙二醇,N,N-二甲基甲酰胺二乙基缩醛 反应 2.0H,以80%的收率获得2-二甲基氨基-1,3-二氧环戊烷
参考文献:4-氯-5-氰基-1,2,3-三唑与原甲酸衍生物的n-烷基化
标题:4-氯-5-氰基-1,2,3-三唑与原甲酸衍生物的n-烷基化
摘要:
Doi:10.1007/bf00633170

专利信息

专利号:US-8030496-B2
优先权日:2005-02-17
标 题:Intermediate compound for synthesis of viridiofungin a derivative
发明人：KATO TATSUYA; KIMURA NOBUAKI; MIZUTANI AKEMI; MAKINO TOSHIHIKO; KAWASAKI KENICHI; FUKUDA HIROSHI; KOMIYAMA SUSUMU; TSUKUDA TAKUO
权利人:CHUGAI PHARMACEUTICAL CO LTD
摘要:A method whereby a compound having HCV replication inhibitory activity and desired optical activity can be synthesized selectively and at high yield in a small number of steps by using a compound having a specific chiral auxiliary as a starting compound is provided. n A compound represented by the formula (1-8): n n n n n n n n n n n n wherein Y represents a group represented by the following formula: n n n n n n n n n n n n n n n n Q represents a protected carbonyl group; D represents —(CH 2 ) m —R′, etc.; and n represents an integer of 0 to 10.

专利号:US-7897783-B2
优先权日:2005-02-17
标题 :Intermediate compound for synthesis of viridiofungin a derivative

专利号:US-4073795-A
优先权日:1976-06-22
标 题:Synthesis of tryptophans

专利号:US-2010152456-A1
优先权日:2005-02-17
标题 :Intermediate compound for synthesis of viridiofungin a derivative

专利号:US-2010152457-A1
优先权日:2005-02-17
标 题 :Intermediate compound for synthesis of viridiofungin a derivative

专利号:US-2008176857-A1
优先权日:2005-03-25
标题 :4-Piperazinnylthieno[2,3-d]Pyrimidine Compounds as Platelet Aggregation Inhibitors
发明人：ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH
权利人:ENNIS MICHAEL DALTON; KORTUM STEVEN WADE; TENBRINK RUTH ELIZABETH
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I: n n n n n n n n n n wherein A 1 , A 2 , A 3 , A 4 , A 5 , A 6 , A 7 , A 8 , X 4 , X 6 , R 2 , R 4 , R 5 , and R 6 are as defined in the detailed description of the invention. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.